Metreleptin Injectable Solution bulk supplier for pharma manufacturers

Metreleptin Injectable Solution 11.3 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 11.3 mg/vial

Reference Brands: Myalept(US & EU)

Metreleptin injectable solution replaces leptin, a hormone regulating appetite, metabolism, and insulin sensitivity. It improves metabolic control, reduces hunger, and manages lipodystrophy-related complications. Benefits include decreased insulin resistance, better lipid profiles, enhanced energy, and weight stabilization, supporting overall metabolic health in leptin-deficient patients worldwide.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Metreleptin Injectable Solution? List it or send an offer →

Product Description: Metreleptin injectable solution, marketed as Myalept, is approved in the US by the FDA and in the EU via EMA for leptin deficiency associated with lipodystrophy. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. Proper adherence supports swift approval, safe administration, and global availability, helping patients with leptin deficiency manage metabolic disorders effectively worldwide.

Metreleptin Injectable Solution — third party manufacturing & bulk supply

Metreleptin Injectable Solution 11.3 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Metreleptin Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Metreleptin Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Metreleptin Injectable Solution →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Metreleptin Injectable Solution is listed as Injectable Solution in 11.3 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Metreleptin Injectable Solution is referenced against Myalept(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.